Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

New England Journal of Medicine - Tập 358 Số 26 - Trang 2776-2786 - 2008
Michael R. Lassen1, Walter Ageno2, I. Scharrer3, Jay R. Lieberman4, Nadia Rosencher5, Tiemo‐Joerg Bandel6, Frank Misselwitz6, Raimondo De Cristofaro7
1Nordsjællands Hospital, Hørsholm, Denmark
2University of Insubria, Varese, Italy
3Aarhus University Hospital, Aarhus, Denmark
4Department of Orthopaedic Surgery, University of Connecticut Health Center, Farmington
5Paris Descartes University, Cochin Hospital, Paris
6Bayer HealthCare, Wuppertal, Germany
7McMaster University, Hamilton, ON, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1378/chest.126.3_suppl.338S

10.1161/ATVBAHA.107.139402

10.1001/archinte.162.16.1833

10.1111/j.1538-7836.2005.01166.x

10.1016/j.thromres.2006.12.025

10.1111/j.1538-7836.2005.01657.x

10.1111/j.1538-7836.2005.01602.x

10.1161/CIRCULATIONAHA.106.642074

10.1001/archsurg.1972.04180020014004

10.2106/JBJS.D.02184

10.1056/NEJMoa011099

10.1161/CIRCULATIONAHA.106.668020

10.1185/030079906X89801

10.1056/NEJMoa035162

Lassen MR, 2003, Blood, 102, 15a

Lassen MR, 2006, Blood, 108, 173a, 10.1182/blood.V108.11.574.574

Friedman RJ, 2007, J Thromb Haemost, 5, Suppl 1, 10.1111/j.1538-7836.2007.tb00032.x

10.1001/archinte.161.18.2215

Comp PC, 2001, J Bone Joint Surg Am, 83, 336, 10.2106/00004623-200103000-00004

10.1016/S0140-6736(07)61445-7